News and Trends 14 Oct 2022 Mablink Bioscience receives €31M series A funding for ADC pipeline French biotech company Mablink Bioscience has raised €31 million ($30.3 million) in series A funding to advance its lead candidate to the clinic and to build a pipeline of antibody… October 14, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 25 Sep 2019 German Biotech Will Develop Carbohydrate-Targeting Cancer Treatments The German startup Tacalyx has raised €7M in a seed round to fund the preclinical development of first-in-class carbohydrate-targeting antibody drugs for the treatment of cancer. The round was co-led… September 25, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Jul 2023 Six companies driving Chennai’s biotech scene …modified peptides of large quantities. It also conducts epigenomic profiling which entails chromatin, RNA sequencing and DNA methylation analysis. The Chennai-based biotech company’s antibody development includes production of antibody fragments… July 28, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Nov 2025 11 neuroscience biotech companies you should know about …which the neuroscience company announced the completion of the second dose cohort in May. BioArctic Technology: Antibody therapies Notable neuroscience product: Leqembi for Alzheimer’s disease Recent news: Entered into a… November 25, 2025 - 16 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 17 Jul 2020 Two UK Startups Raise Seed Funding to Revolutionize Cancer Treatment …is developing engineered antibodies called antibody-drug conjugates, which are designed to recognize cancer cells and release their chemotherapy drug payload in a targeted manner. This idea has been explored by… July 17, 2020 - 3 minutesmins - By Kostas Vavitsas Share WhatsApp Twitter Linkedin Email
More News! 12 Nov 2018 This UK Biotech Wants to Make Antibodies Easy to Swallow Say goodbye to painful antibody injections. The UK biotech Intract Pharma has received a €1.6M grant to advance oral immunotherapy based on approved antibodies, causing less discomfort for patients. The… November 12, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 4 Dec 2024 Idiopathic pulmonary fibrosis: Refoxy, Boehringer, Insilico, and more on the hunt for curative treatments …several failed clinical attempts to beat Ofev and Esbriet. These include California-based FibroGen’s anti-CTGF antibody pamrevlumab, Belgian biotech Galapagos and Gilead’s autotaxin inhibitor ziritaxestat, and Massachusetts-based Galecto’s galectin-3 inhibitor GB0139,… December 4, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 9 May 2024 BTK inhibitors: can these drugs tackle cancer and autoimmunity? …soon, rilzabrutinib could give competition to Swiss multinationals Novartis and Roche’s monoclonal antibody Xolair, which is also given to patients with CSU. Moreover, the readout of the phase 2 asthma… May 9, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 4 Feb 2021 HIV Drug Approvals Lift Hopes Amid Missed UN Targets …project developing these antibody drugs — known as the Antibody Mediated Prevention (AMP) studies — found no strong evidence that the drugs could prevent HIV overall. Other biotechs are exploring… February 4, 2021 - 6 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Dec 2024 Five biosimilar companies you should know about …antibody that prevents abnormal regulation of interleukin IL-12 and IL-23-associated immune diseases and is intended for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis. The approval… December 5, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 6 Oct 2022 15 biotech companies shaking up the scene in Cambridge …major biotech and pharma hub. Antibody development is one of the strengths of the city thanks to the legacy of Cambridge Antibody Technologies, which pioneered the technology of phage display… October 6, 2022 - 9 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
In Depth 11 Oct 2023 Project NextGen: The U.S. government’s $5 billion initiative to stay one step ahead of COVID-19 …for a new monoclonal antibody, and $100 million to explore novel vaccine and therapeutic technologies that will help to streamline the manufacturing process. To be more specific, the $1 billion… October 11, 2023 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email